Solid Biosciences Inc.
SLDB- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001707502
No open-market purchases or sales by Solid Biosciences Inc. insiders were filed in the last 90 days; 157 institutions reported holding it in 13F filings for Q2 2026, worth $1.14B in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Solid Biosciences Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 132
- +3 vs. Q3 2025
- Shares held
- 81.4M
- −482.9K (−0.6%) vs. Q3 2025
- Total value
- $459.2M
- −$46.0M (−9.1%) vs. Q3 2025
- New holders
- 14
- 37 more added
- Sold out
- 11
- 47 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SLDB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 157 | $1.14B |
| Q1 2026 | 150 | $717.4M |
| Q4 2025 | 132 | $459.2M |
| Q3 2025 | 129 | $505.2M |
| Q2 2025 | 116 | $403.4M |
| Q1 2025 | 125 | $293.2M |
| Q4 2024 | 90 | $145.3M |
| Q3 2024 | 92 | $249.8M |
| Q2 2024 | 80 | $213.2M |
| Q1 2024 | 56 | $465.9M |
| Q4 2023 | 40 | $102.2M |
| Q3 2023 | 37 | $40.7M |
| Q2 2023 | 36 | $85.6M |
| Q1 2023 | 39 | $74.8M |
| Q4 2022 | 35 | $85.6M |
| Q3 2022 | 58 | $33.4M |
| Q2 2022 | 67 | $39.5M |
| Q1 2022 | 78 | $83.3M |
| Q4 2021 | 82 | $132.2M |
| Q3 2021 | 91 | $184.3M |
| Q2 2021 | 92 | $293.4M |
| Q1 2021 | 104 | $437.6M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Solid Biosciences Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 344,294 | $1.94M | 0.00% | −445,702−56.4% | Reduced |
| Balyasny Asset Management LLC | 360,937 | $2.04M | 0.00% | −371,671−50.7% | Reduced |
| Morgan Stanley | 394,266 | $2.22M | 0.00% | +136,420+52.9% | Added |
| Nuveen, LLC | 394,976 | $2.23M | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 412,777 | $2.33M | 0.00% | −33,739−7.6% | Reduced |
| Ally Bridge Group (NY) LLC | 413,625 | $2.33M | 3.70% | −135,557−24.7% | Reduced |
| Parkman Healthcare Partners LLC | 418,371 | $2.36M | 0.22% | +21,975+5.5% | Added |
| Susquehanna International Group, LLP | 499,293 | $2.82M | 0.00% | −4,373−0.9% | Reduced |
| Dimensional Fund Advisors LP | 679,084 | $3.83M | 0.00% | +235,543+53.1% | Added |
| Birchview Capital, LP | 705,955 | $3.98M | 2.33% | +409,000+137.7% | Added |
| UBS Group AG | 911,409 | $5.14M | 0.00% | +187,264+25.9% | Added |
| Finepoint Capital LP | 961,251 | $5.42M | 1.02% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 1,006,306 | $5.68M | 0.00% | +329,679+48.7% | Added |
| State Street Corp | 1,087,413 | $6.13M | 0.00% | −5,886−0.5% | Reduced |
| Geode Capital Management, LLC | 1,267,392 | $7.15M | 0.00% | −19,851−1.5% | Reduced |
| Monashee Investment Management LLC | 1,349,771 | $7.61M | 4.29% | +1,349,771 | New |
| Adage Capital Partners GP, L.L.C. | 1,400,000 | $7.90M | 0.01% | −2,600,000−65.0% | Reduced |
| Franklin Resources Inc | 1,599,233 | $9.02M | 0.00% | +10.0% | Added |
| Nantahala Capital Management, LLC | 1,603,336 | $9.04M | 0.54% | −95,922−5.6% | Reduced |
| Alyeska Investment Group, L.P. | 1,682,805 | $9.49M | 0.03% | 00.0% | Unchanged |
| Redmile Group, LLC | 1,860,542 | $10.5M | 0.77% | −38,800−2.0% | Reduced |
| FMR LLC | 2,029,898 | $11.4M | 0.00% | −884,229−30.3% | Reduced |
| Point72 Asset Management, L.P. | 2,416,108 | $13.6M | 0.02% | +1,083,103+81.3% | Added |
| Armistice Capital, LLC | 2,612,000 | $14.7M | 0.36% | +1,676,000+179.1% | Added |
| Citadel Advisors LLC | 2,663,863 | $15.0M | 0.01% | +71,166+2.7% | Added |
| Vanguard Group Inc | 3,454,959 | $19.5M | 0.00% | +371,109+12.0% | Added |
| BlackRock, Inc. | 4,869,682 | $27.5M | 0.00% | +144,564+3.1% | Added |
| Ra Capital Management, L.P. | 5,811,423 | $32.8M | 0.34% | 00.0% | Unchanged |
| Vestal Point Capital, LP | 5,815,000 | $32.8M | 1.20% | +2,840,000+95.5% | Added |
| Siren, L.L.C. | 7,690,405 | $43.4M | 1.29% | +274,500+3.7% | Added |
| Bain Capital Life Sciences Investors, LLC | 7,911,669 | $44.6M | 3.42% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 11,833,539 | $66.7M | 1.22% | 00.0% | Unchanged |
| MPM Oncology Impact Management LP | 0 | $0 | 0.00% | −1,634,569−100.0% | Sold out |
| Sectoral Asset Management Inc | 0 | $0 | 0.00% | −633,052−100.0% | Sold out |
| Schroder Investment Management Group | 0 | $0 | 0.00% | −490,902−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −70,448−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −60,990−100.0% | Sold out |
| SFMG, LLC | 0 | $0 | 0.00% | −25,031−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −23,584−100.0% | Sold out |
| Polymer Capital Management (US) LLC | 0 | $0 | 0.00% | −15,264−100.0% | Sold out |
| Pallas Capital Advisors LLC | 0 | $0 | 0.00% | −11,145−100.0% | Sold out |
| SRS Capital Advisors, Inc. | 0 | $0 | 0.00% | −9,200−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −228−100.0% | Sold out |